China’s Sinovac secures $500 million in underwriting for Covid-19 vaccine development – world news

0
42

[ad_1]

Home / World News / China’s Sinovac secures $500 million in underwriting for Covid-19 vaccine development

In a commentary on its website, the company said it expects as a way to manufacture 300 million vaccine doses yearly, and that it aims to total construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.
world
Up to date: Dec 07, 2020, 06:23 IST



Sinovac said the investor is Sino Biopharmaceutical Ltd.(Reuters)

China’s Sinovac Biotech said on Monday that it had secured about $500 million in underwriting for Covid-19 vaccine development.

In a commentary on its website, the company said it expects as a way to manufacture 300 million vaccine doses yearly, and that it aims to total construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.

Sinovac said the investor is Sino Biopharmaceutical Ltd.


Thank you for subscribing to our day by day newsletter.

[ad_2]

Top stories/ News / India

LEAVE A REPLY

Please enter your comment!
Please enter your name here